Amanda Phipps, Ph.D., M.P.H.

Amanda Phipps Ph.D., M.P.H.
FACULTY MEMBER

Amanda Phipps, Ph.D., M.P.H.

Assistant Member
Public Health Sciences Division, Fred Hutch

Fax: 206.667.7850
Mail Stop: M4-C308

Dr. Amanda Phipps is an epidemiologist who identifies how aspects of tumor biology and lifestyle factors, like smoking and physical activity, affect cancer survival. Working with studies like the Genetics and Epidemiology of Colorectal Cancer Consortium, or GECCO, Dr. Phipps identifies genetic factors and tumor attributes that contribute to colorectal cancer patients’ prognosis. She also studies the relationship between obstructive sleep apnea and cancer. Another research interest focuses on risk factors related to triple-negative breast cancer and other molecular subtypes of the disease.

Other Appointments & Affiliations

Associate Professor of Epidemiology
University of Washington

Education

Ph.D., University of Washington, Epidemiology, 2010.

M.P.H., University of California, Berkeley, Epidemiology and Biostatistics, 2003.

B.A., Northwestern University, Molecular and Cell Biology, 2001.

Research Interests

Dr. Phipps’ research interests span the fields of cancer epidemiology, molecular epidemiology, and clinical epidemiology. In particular, her work is focused on identifying ways in which cancer survival differs according to aspects of a patient’s lifestyle (e.g., smoking, physical activity) and aspects of tumor biology (e.g., KRAS mutation status, microsatellite instability, tumor microbiome). Her current projects focus on the relationship of modifiable lifestyle behaviors and the tumor-associated microbiome with survival in individuals with biologically-distinct subtypes of colorectal cancer, and on the relationship between obstructive sleep apnea and cancer. She is also working to identify the role of lifestyle factors in how cancer patients respond to certain forms of cancer treatment. In addition to her current work in colorectal cancer survival, she has an interest in molecular subtypes of breast cancer, particularly in risk factors for the poor-prognosis triple-negative subtype of breast cancer.

Find a Clinical Trial

For the Media

The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.

Email media@fredhutch.org or call 206.667.2210.